237 related articles for article (PubMed ID: 22247889)
21. Developing a Flexible Pediatric Dosage Form for Antiretroviral Therapy: A Fast-Dissolving Tablet.
Lal M; Lai M; Estrada M; Zhu C
J Pharm Sci; 2017 Aug; 106(8):2173-2177. PubMed ID: 28499879
[TBL] [Abstract][Full Text] [Related]
22. Formulation and evaluation of aceclofenac mouth-dissolving tablet.
Solanki SS; Dahima R
J Adv Pharm Technol Res; 2011 Apr; 2(2):128-31. PubMed ID: 22171305
[TBL] [Abstract][Full Text] [Related]
23. A review of emerging technologies enabling improved solid oral dosage form manufacturing and processing.
Sohail Arshad M; Zafar S; Yousef B; Alyassin Y; Ali R; AlAsiri A; Chang MW; Ahmad Z; Ali Elkordy A; Faheem A; Pitt K
Adv Drug Deliv Rev; 2021 Nov; 178():113840. PubMed ID: 34147533
[TBL] [Abstract][Full Text] [Related]
24. Formulation and Taste Masking of Ranitidine Orally Disintegrating Tablet.
Hesari Z; Shafiee A; Hooshfar S; Mobarra N; Mortazavi SA
Iran J Pharm Res; 2016; 15(4):677-686. PubMed ID: 28243264
[TBL] [Abstract][Full Text] [Related]
25. Tolmetin Sodium Fast Dissolving Tablets for Rheumatoid Arthritis Treatment: Preparation and Optimization Using Box-Behnken Design and Response Surface Methodology.
Elsayed MMA; Aboelez MO; Elsadek BEM; Sarhan HA; Khaled KA; Belal A; Khames A; Hassan YA; Abdel-Rheem AA; Elkaeed EB; Raafat M; Elsadek MEM
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456714
[TBL] [Abstract][Full Text] [Related]
26. Mesoporous Pravastatin Solid Dispersion Granules Incorporable Into Orally Disintegrating Tablets.
Song H; Moon C; Lee BJ; Oh E
J Pharm Sci; 2018 Jul; 107(7):1886-1895. PubMed ID: 29530714
[TBL] [Abstract][Full Text] [Related]
27. [Oral disintegrating tablets. A new, modern, solid dosage form].
Popa G; Gafiţanu E
Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):337-42. PubMed ID: 14755937
[TBL] [Abstract][Full Text] [Related]
28. A pharmaceutical study on lornoxicam fast disintegrating tablets: formulation and in vitro and in vivo evaluation.
Moutasim MY; ElMeshad AN; El-Nabarawi MA
Drug Deliv Transl Res; 2017 Jun; 7(3):450-459. PubMed ID: 28283842
[TBL] [Abstract][Full Text] [Related]
29. Oral Disintegrating Tablets of Proton Pump Inhibitors for Chronic Gastroesophageal Reflux Disease: An Update.
Gupta A; Akhtar J; Rastogi KC; Badruddeen ; Khan MI; Ahmad M
Curr Drug Res Rev; 2023; 15(3):199-206. PubMed ID: 36824005
[TBL] [Abstract][Full Text] [Related]
30. Taste masking microspheres for orally disintegrating tablets.
Xu J; Bovet LL; Zhao K
Int J Pharm; 2008 Jul; 359(1-2):63-9. PubMed ID: 18455893
[TBL] [Abstract][Full Text] [Related]
31. Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives.
Ghourichay MP; Kiaie SH; Nokhodchi A; Javadzadeh Y
Biomed Res Int; 2021; 2021():6618934. PubMed ID: 34977245
[TBL] [Abstract][Full Text] [Related]
32. Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidate.
Lal M; Priddy S; Bourgeois L; Walker R; Pebley W; Brown J; Desai J; Darsley MJ; Kristensen D; Chen D
Vaccine; 2013 Oct; 31(42):4759-64. PubMed ID: 23965220
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of dissolution rate and oral bioavailability of poorly soluble drug florfenicol by using solid dispersion and effervescent disintegration technology.
Li C; Li N; Chen X; Li X; Liu C; Abbas A; Wang Y; Qi S; Zhang Y; Li D; Zhang W; Shu G; Lin J; Li H; Xu F; Peng G; Fu H
Drug Dev Ind Pharm; 2024 Jan; 50(1):45-54. PubMed ID: 38095592
[TBL] [Abstract][Full Text] [Related]
34. Challenges and emerging solutions in the development of compressed orally disintegrating tablets.
Al-Khattawi A; Mohammed AR
Expert Opin Drug Discov; 2014 Oct; 9(10):1109-20. PubMed ID: 25045997
[TBL] [Abstract][Full Text] [Related]
35. Orally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use.
Comoglu T; Dilek Ozyilmaz E
Pharm Dev Technol; 2019 Sep; 24(7):902-914. PubMed ID: 31215850
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
[TBL] [Abstract][Full Text] [Related]
37. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets.
Chandrasekhar R; Hassan Z; Alhusban F; Smith AM; Mohammed AR
Eur J Pharm Biopharm; 2009 May; 72(1):119-29. PubMed ID: 19073253
[TBL] [Abstract][Full Text] [Related]
38. Formulation and development of taste masked fast-disintegrating tablets (FDTs) of Chlorpheniramine maleate using ion-exchange resins.
Yewale CP; Rathi MN; Kore GG; Jadhav GV; Wagh MP
Pharm Dev Technol; 2013; 18(2):367-76. PubMed ID: 22023351
[TBL] [Abstract][Full Text] [Related]
39. [Preparation of orally disintegrating tablets for masking of unpleasant taste: comparison with corrective-adding methods].
Kawano Y; Ito A; Sasatsu M; Machida Y
Yakugaku Zasshi; 2010 Jan; 130(1):75-80. PubMed ID: 20046069
[TBL] [Abstract][Full Text] [Related]
40. Application of biorelevant saliva-based dissolution for optimisation of orally disintegrating formulations of felodipine.
Ali J; Zgair A; Hameed GS; Garnett MC; Roberts CJ; Burley JC; Gershkovich P
Int J Pharm; 2019 Jan; 555():228-236. PubMed ID: 30465852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
